nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—Dexmethylphenidate—SLC6A3—attention deficit hyperactivity disorder	0.0125	0.286	CrCbGaD
Ipratropium bromide—Methylphenidate—SLC6A3—attention deficit hyperactivity disorder	0.0125	0.286	CrCbGaD
Ipratropium bromide—Dexmethylphenidate—SLC6A4—attention deficit hyperactivity disorder	0.00933	0.214	CrCbGaD
Ipratropium bromide—Methylphenidate—SLC6A4—attention deficit hyperactivity disorder	0.00933	0.214	CrCbGaD
Ipratropium bromide—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00764	0.0696	CbGeAlD
Ipratropium bromide—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00695	0.0634	CbGeAlD
Ipratropium bromide—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00646	0.0589	CbGeAlD
Ipratropium bromide—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00622	0.0567	CbGeAlD
Ipratropium bromide—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00604	0.0551	CbGeAlD
Ipratropium bromide—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.00588	0.0536	CbGeAlD
Ipratropium bromide—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00582	0.053	CbGeAlD
Ipratropium bromide—CHRM5—brain—attention deficit hyperactivity disorder	0.00462	0.0421	CbGeAlD
Ipratropium bromide—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00415	0.0378	CbGeAlD
Ipratropium bromide—SLC22A4—cerebellum—attention deficit hyperactivity disorder	0.00403	0.0367	CbGeAlD
Ipratropium bromide—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00399	0.0364	CbGeAlD
Ipratropium bromide—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00378	0.0344	CbGeAlD
Ipratropium bromide—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00363	0.0331	CbGeAlD
Ipratropium bromide—SLC22A5—midbrain—attention deficit hyperactivity disorder	0.00344	0.0314	CbGeAlD
Ipratropium bromide—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00338	0.0308	CbGeAlD
Ipratropium bromide—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00337	0.0307	CbGeAlD
Ipratropium bromide—SLC22A4—brain—attention deficit hyperactivity disorder	0.00327	0.0298	CbGeAlD
Ipratropium bromide—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00325	0.0296	CbGeAlD
Ipratropium bromide—CHRM2—brain—attention deficit hyperactivity disorder	0.00317	0.0289	CbGeAlD
Ipratropium bromide—CHRM1—brain—attention deficit hyperactivity disorder	0.00289	0.0263	CbGeAlD
Ipratropium bromide—SLC22A5—cerebellum—attention deficit hyperactivity disorder	0.00266	0.0243	CbGeAlD
Ipratropium bromide—CHRM3—brain—attention deficit hyperactivity disorder	0.00258	0.0235	CbGeAlD
Ipratropium bromide—SLC22A5—brain—attention deficit hyperactivity disorder	0.00216	0.0197	CbGeAlD
Ipratropium bromide—CYP3A4—nervous system—attention deficit hyperactivity disorder	0.00186	0.0169	CbGeAlD
Ipratropium bromide—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.00183	0.0166	CbGeAlD
Ipratropium bromide—CYP3A4—central nervous system—attention deficit hyperactivity disorder	0.00179	0.0163	CbGeAlD
Ipratropium bromide—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.00176	0.016	CbGeAlD
Ipratropium bromide—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.00172	0.0157	CbGeAlD
Ipratropium bromide—CYP2D6—brain—attention deficit hyperactivity disorder	0.0014	0.0127	CbGeAlD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00124	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.00105	0.00124	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00105	0.00123	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00104	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00104	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00103	0.00122	CbGpPWpGaD
Ipratropium bromide—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00103	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00102	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00102	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00102	0.00121	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00102	0.0012	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00101	0.0012	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.001	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.000998	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000997	0.00118	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000994	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000989	0.00117	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.000984	0.00116	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000972	0.00115	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000965	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000962	0.00114	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00096	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00096	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.000953	0.00113	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00095	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000944	0.00112	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000941	0.00111	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.000932	0.0011	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00093	0.0011	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000914	0.00108	CbGpPWpGaD
Ipratropium bromide—SLC22A5—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000913	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000911	0.00108	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.000903	0.00107	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000899	0.00106	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000896	0.00106	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000894	0.00106	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000888	0.00105	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.000887	0.00105	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000885	0.00105	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000885	0.00104	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000882	0.00104	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.000876	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000874	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.000873	0.00103	CbGpPWpGaD
Ipratropium bromide—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.000872	0.00103	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.000841	0.000994	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000836	0.000988	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000827	0.000977	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000824	0.000974	CbGpPWpGaD
Ipratropium bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000822	0.000971	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000816	0.000964	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000782	0.000924	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00078	0.000921	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000773	0.000913	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000771	0.00091	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000763	0.000902	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000736	0.00087	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000734	0.000867	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000727	0.000858	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000721	0.000852	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000719	0.000849	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000719	0.000849	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000717	0.000846	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000712	0.000841	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.00071	0.000839	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00071	0.000838	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000696	0.000822	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000694	0.00082	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000688	0.000813	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000687	0.000812	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000684	0.000808	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000684	0.000807	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000682	0.000806	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000679	0.000802	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000676	0.000798	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000676	0.000798	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000676	0.000798	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000674	0.000796	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000674	0.000796	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000669	0.00079	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000667	0.000788	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000667	0.000788	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000666	0.000787	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00066	0.00078	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000655	0.000774	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000653	0.000771	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000653	0.000771	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000647	0.000764	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000645	0.000762	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00063	0.000744	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000628	0.000741	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000626	0.00074	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000622	0.000734	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000621	0.000733	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000589	0.000696	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000587	0.000693	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000581	0.000687	CbGpPWpGaD
Ipratropium bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000579	0.000684	CbGpPWpGaD
Ipratropium bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000577	0.000682	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000577	0.000681	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000572	0.000675	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000564	0.000666	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000561	0.000663	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000559	0.00066	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00055	0.000649	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000549	0.000649	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000542	0.000641	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000539	0.000637	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000529	0.000624	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000524	0.000619	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000507	0.000599	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000505	0.000597	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0005	0.000591	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000499	0.000589	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000498	0.000589	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000494	0.000583	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000493	0.000582	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000471	0.000556	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00046	0.000543	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000459	0.000542	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000458	0.000541	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000454	0.000536	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000454	0.000536	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000453	0.000535	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.00045	0.000532	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000448	0.000529	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000447	0.000528	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.000444	0.000524	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000441	0.000521	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00044	0.000519	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000437	0.000516	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000437	0.000516	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000436	0.000515	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000435	0.000514	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000431	0.00051	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000406	0.00048	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000405	0.000478	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000401	0.000474	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000397	0.000469	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000396	0.000467	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000395	0.000466	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000394	0.000465	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000393	0.000465	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000392	0.000463	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000392	0.000463	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00039	0.00046	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000388	0.000459	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000387	0.000457	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000387	0.000457	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000386	0.000456	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000386	0.000455	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000382	0.000451	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000382	0.000451	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000382	0.000451	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000381	0.00045	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000381	0.00045	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000379	0.000448	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000378	0.000447	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000377	0.000445	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000375	0.000442	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000369	0.000436	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000368	0.000434	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000364	0.00043	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000357	0.000422	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000356	0.000421	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000356	0.00042	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000355	0.000419	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000354	0.000418	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000353	0.000417	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000351	0.000415	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000351	0.000415	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00035	0.000413	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000347	0.00041	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000347	0.000409	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000346	0.000408	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000342	0.000404	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000333	0.000393	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000325	0.000384	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000325	0.000384	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000323	0.000382	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000322	0.00038	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000321	0.00038	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.00032	0.000378	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000319	0.000377	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00031	0.000366	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.0003	0.000354	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000297	0.000351	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000295	0.000348	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000291	0.000344	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000282	0.000333	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000271	0.00032	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000268	0.000317	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000267	0.000316	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000265	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.00026	0.000307	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000249	0.000294	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000248	0.000293	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000247	0.000292	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000246	0.000291	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000234	0.000277	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000234	0.000276	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000231	0.000273	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000226	0.000267	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000226	0.000266	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000223	0.000264	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000218	0.000257	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000217	0.000257	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000215	0.000254	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000211	0.000249	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00021	0.000249	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000208	0.000246	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000207	0.000245	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000207	0.000244	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000205	0.000242	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000205	0.000242	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000204	0.000241	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000202	0.000239	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000197	0.000233	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000196	0.000231	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000194	0.00023	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000194	0.00023	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000191	0.000226	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000191	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00019	0.000225	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.00019	0.000224	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000188	0.000223	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000184	0.000217	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000178	0.00021	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000155	0.000183	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000148	0.000175	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000134	0.000158	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000133	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000132	0.000156	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000127	0.00015	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000127	0.00015	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000125	0.000148	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	0.000118	0.000139	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000117	0.000138	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000116	0.000137	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000102	0.00012	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000101	0.000119	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ADRA2A—attention deficit hyperactivity disorder	9.67e-05	0.000114	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	8.44e-05	9.97e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—COMT—attention deficit hyperactivity disorder	7.7e-05	9.09e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—MAOA—attention deficit hyperactivity disorder	7.64e-05	9.03e-05	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.08e-05	8.37e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.06e-05	8.34e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	6.99e-05	8.26e-05	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	5.05e-05	5.96e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—EP300—attention deficit hyperactivity disorder	3.3e-05	3.9e-05	CbGpPWpGaD
